Remission by composite scores in rheumatoid arthritis: Are ankles and feet important?

Arthritis Research and Therapy

Volumn 9, Issue 4, 2007, Pages

  Kapral, Theresa ^a   Dernoschnig, Florian ^a   Machold, Klaus P ^a   Stamm, Tanja ^a   Schoels, Monika ^b   Smolen, Josef S ^a,b   Aletaha, Daniel ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b HIETZING HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

RHEUMATOID FACTOR; ANTIRHEUMATIC AGENT;

ADULT; ANKLE; ARTICLE; CLINICAL EVALUATION; DATA ANALYSIS; DISEASE ACTIVITY; FEMALE; FOOT; HUMAN; JOINT EXAMINATION; JOINT SWELLING; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METATARSOPHALANGEAL JOINT; OBSERVATIONAL STUDY; PREDICTIVE VALIDITY; REMISSION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; HEALTH STATUS; HOSPITALIZATION; MIDDLE AGED; OUTPATIENT; PATHOLOGY; PREDICTION AND FORECASTING; QUESTIONNAIRE; TREATMENT OUTCOME;

ANKLE JOINT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 34548079733     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2270     Document Type: Article

References (29)

1. Molenaar ET Voskuyl AE Dinant HJ Bezemer PD Boers M Dijkmans BA Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum 2004, 50:36-42. 10.1002/art.11481 14730597
2. Emery P Salmon M Early rheumatoid arthritis: time to aim for remission? Ann Rheum Dis 1995, 54:944-947. 1010056 8546524
3. O'Dell JR Therapeutic strategies for rheumatoid arthritis, N Engl J Med 2004, 350:2591-2602. 10.1056/NEJMra040226 15201416
4. Sharp JT Lidsky MD Duffy J Clinical responses during gold therapy for rheumatoid arthritis. Changes in synovitis, radiologically detectable erosive lesions, serum proteins, and serologic abnormalities. Arthritis Rheum 1982, 25:540-549. 10.1002/art.1780250508 7044386
5. Scott DL Coulton BL Bacon PA Popert AJ Methods of x-ray assessment in rheumatoid arthritis: a re-evaluation. Br J Rheumatol 1985, 24:31-39. 10.1093/rheumatology/24.1.31 3978364
6. Fuchs HA Callahan LF Kaye JJ Brooks RH Nance EP Pincus T Radiographic and joint count findings of the hand in rheumatoid arthritis. Related and unrelated findings. Arthritis Rheum 1988, 31:44-51. 10.1002/ art.1780310107 3345231
7. Pincus T Callahan LF Quantitative measures to assess, monitor and predict morbidity and mortality in rheumatoid arthritis. Baillieres Clin Rheumatol 1992, 6:161-191. 10.1016/S0950-3579(05)80343-7 1563035
8. Aletaha D Smolen JS The definition and measurement of disease modification in inflammatory rheumatic diseases. Rheum Dis Clin North Am 2006, 32:9-44. 10.1016/j.rdc.2005.09.005 16504819
9. Dougados M Emery P Lemmel EM Zerbini CA Brin S van Riel P When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide? Ann Rheum Dis 2005, 64:44-51. 10.1136/ ard.2003.016709 15271770
10. Flendrie M Creemers MC Welsing PM van Riel PL The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study. Rheumatology (Oxford) 2005, 44:472-478. 10.1093/ rheumatology/keh508 15598707
11. Emery P Breedveld FC Lemmel EM Kaltwasser JP Dawes PT Gömör B Van Den Bosch F Nordström D Bjorneboe O Dahl R A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology (Oxford) 2000, 39:655-665. 10.1093/rheumatology/39.6.655 10888712
12. Fuchs HA Pincus T Reduced joint counts in controlled clinical trials in rheumatoid arthritis. Arthritis Rheum 1994, 37:470-475. 10.1002/ art.1780370406 8147923
13. Smolen JS Breedveld FC Eberl G Jones I Leeming M Wylie GL Kirkpatrick J Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity. Arthritis Rheum 1995, 38:38-43. 10.1002/art.1780380106 7818569
14. Landewé R van der Heijde D van der Linden S Boers M Twenty-eight-joint counts invalidate the DAS28 remission definition owing to the omission of the lower extremity joints: a comparison with the original DAS remission. Ann Rheum Dis 2006, 65:637-641. 10.1136/ ard.2005.039859 16219709
15. Arnett FC Edworthy SM Bloch DA McShane DJ Fries JF Cooper NS Healey LA Kaplan SR Liang MH Luthra HS The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302 3358796
16. Aletaha D Smolen JS The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses. Rheumatology (Oxford) 2002, 41:1367-1374. 10.1093/rheumatology/41.12.1367 12468815
17. Aletaha D Smolen JS Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational study. J Rheumatol 2002, 29:1631-1638. 12180721
18. Aletaha D Smolen JS Laboratory testing in rheumatoid arthritis patients taking disease-modifying antirheumatic drugs: clinical evaluation and cost analysis. Arthritis Rheum 2002, 47:181-188. 10.1002/art.10266 11954012
19. Fries JF Spitz P Kraines RG Holman HR Measurement of patient outcome in arthritis. Arthritis Rheum 1980, 23:137-145. 10.1002/art.1780230202 7362664
20. Prevoo ML van 't Hof MA Kuper HH van Leeuwen MA van de Putte LB van Riel PL Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:44-48. 10.1002/art.1780380107 7818570
21. Smolen JS Breedveld FC Schiff MH Kalden JR Emery P Eberl G van Riel PL Tugwell P A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003, 42:244-257. 10.1093/rheumatology/keg072 12595618
22. Fransen J Creemers MC van Riel PL Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology (Oxford) 2004, 43:1252-1255. 10.1093/ rheumatology/keh297 15238643
23. Aletaha D Ward MM Machold KP Nell VP Stamm T Smolen JS Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum 2005, 52:2625-2636. 10.1002/art.21235 16142705
24. Aletaha D Eberl G Nell VP Machold KP Smolen JS Attitudes to early rheumatoid arthritis: changing patterns. Results of a survey. Ann Rheum Dis 2004, 63:1269-1275. 10.1136/ard.2003.015131 15361385
25. Smolen JS Kalden JR Scott DL Rozman B Kvien TK Larsen A Loew-Friedrich I Oed C Rosenburg R Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial European Leflunomide Study Group. Lancet 1999, 353:259-266. 10.1016/S0140-6736(98)09403-3 9929017
26. Egger MJ Huth DA Ward JR Reading JC Williams HJ Reduced joint count indices in the evaluation of rheumatoid arthritis. Arthritis Rheum 1985, 28:613-619. 10.1002/art.1780280603 3924059
27. Ritchie DM Boyle JA McInnes JM Jasani MK Dalakos TG Grieveson P Buchanan WW Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968, 37:393-406. 4877784
28. Mäkinen H Kautiainen H Hannonen P Sokka T Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis? Ann Rheum Dis 2005, 64:1410-1413. 10.1136/ard.2005.037333 15941836
29. van der Heijde D Klareskog L Boers M Landewé R Codreanu C Bolosiu HD Pedersen R Fatenejad S TEMPO Investigators Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results. Ann Rheum Dis 2005, 64:1582-1587. 10.1136/ ard.2004.034371 15860509